DYSIS Medical Announces Appointment of New Chief Executive and Chief Commercial Officer

DYSIS Medical Ltd, the developer of the innovative DYSIS Ultra Colposcope used in cervical cancer screening, announced today the appointment of Darin Hammers as Chief Executive Officer and a member of the board of directors. In addition, Michael Gioffredi was appointed as Chief Commercial Officer. Former CEO Alastair Atkinson will remain with the company and assume the role of Chief Operating Officer.

“We believe that Mr. Hammers and Mr. Gioffredi have the right leadership experience and knowledge of the U.S. medical device market to establish DYSIS as the leader in Colposcopy. On behalf of all stakeholders, we welcome them to DYSIS"

Prior to joining DYSIS, Darin Hammers was President and CEO of Cogentix Medical which was acquired by Laborie in April of this year. Mr. Hammers’ experience includes over 25 years of leadership roles in urology and gynecology organizations. Prior to joining Cogentix, Mr. Hammers was Vice President of Sales for Bard Medical Division of C.R. Bard and prior spent over 12 years with Boston Scientific in various leadership positions focused on urology and gynecology products. Mr. Hammers earned an MBA from Emory University’s Goizueta School of Business and a BS in Marketing from the University of Southern Indiana.